GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (XSAT:GEAN) » Definitions » Cash Flow for Lease Financing

Genetic Analysis AS (XSAT:GEAN) Cash Flow for Lease Financing : kr-1.51 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genetic Analysis AS Cash Flow for Lease Financing?

Genetic Analysis AS's Cash Flow for Lease Financing for the three months ended in Dec. 2024 was kr-0.38 Mil. Genetic Analysis AS's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was kr-1.51 Mil.

Compared with last quarter (kr-0.38 Mil in Sep. 2024 ), Genetic Analysis AS's Cash Flow for Lease Financing remained the same in Dec. 2024 (kr-0.38 Mil).

Genetic Analysis AS Cash Flow for Lease Financing Historical Data

The historical data trend for Genetic Analysis AS's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Analysis AS Cash Flow for Lease Financing Chart

Genetic Analysis AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial -1.19 -1.06 -1.40 -1.49 -1.51

Genetic Analysis AS Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.37 -0.37 -0.38 -0.38 -0.38

Genetic Analysis AS Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Analysis AS Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Genetic Analysis AS's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Analysis AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (XSAT:GEAN) » Definitions » Cash Flow for Lease Financing
Comparable Companies
NGM:ATANA NGM:LEVBIO OSTO:PROGEN NGM:LUMITO OSTO:IMMNOV XSAT:SPERM OSTO:AROC OSTO:SENZA TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT LH DGX
Traded in Other Exchanges
8V8:Germany
Address
Ulvenveien 80, Oslo, NOR, 0581
Website
https://www.genetic-analysis.com
Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients. Geographically, it operates in the USA, Europe, and the Rest of the world.

Genetic Analysis AS Headlines

No Headlines